This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Why Avoid Individual Stocks highlights the risks of single-stock bets and why broad index funds offer steadier long-term growth for most investors.
22,058 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Could a single Vanguard ETF outpace the S&P 500 in 2026? This article breaks down why broad market exposure, discipli...
Agricultural commodities offer a unique path to diversification and inflation protection. This guide breaks down how ...
Even with a modest $1,000, you can build a steady income stream by selecting the smartest dividend stocks with durabl...
As Anthropic prepares for a public debut, many investors seek exposure to AI beyond private rounds. The AGIX ETF offe...
As AI reshapes computing, three chip giants still worth buying offer a compelling setup for long-term investors. Expl...
Bastion Asset Management just revealed a new stake in Parsons, signaling confidence in steady government spending on ...
A major manager disclosed a sizable stake reduction in BXP, prompting questions about the outlook for Class A office ...
Peter Thiel's hedge fund sold Nvidia shares and shifted into Microsoft and Apple, signaling a strategic pivot in AI b...
Meta’s latest quarter hints at more than just headline growth. This article explains why some investors excited about...
When Warren Buffett stepped aside, Greg Abel took the wheel at Berkshire Hathaway. This article breaks down his first...
SpaceX is entering the IPO spotlight, but valuing a space, AI, and satellite powerhouse is unique. This guide breaks ...